Test Bank For Pharmacotherapeutics For Advanced Practice: A Practical
Approach, 5th Edition (Arcangelo & Peterson) | All Chapters 1–56| Questions &
100% Verified Answers And Rationales | A+ Graded
, T ABLE OF CONT ENT
Chapter 1 : I ssues for the Practitioner in Drug Therapy
Chapter 2: Pharm acokinetic Basis of Therapeutics and Pharm acody nam ic Principles
Chapter 3: I m pact of Drug I nteractions and Adv erse Ev ents on Therapeutics
Chapter 4 : Principles of Pharm acotherapy in Pediatrics, Pregnancy and Lactation
Chapter 5: Pharm acotherapy Principles in O lder Adults
Chapter 6: Principles of Antim icrobial Therapy
Chapter 7: Pharm acogenomics
Chapter 8: The Econom ics of Pharmacotherapeutics
Chapter 9: Principles of Pharm acology in Pain Managem ent
Chapter 1 0: Pain Management in O pioid U se Disorder (O U D) Patients
Chapter 1 1 : Cannabis and Pain Management
Chapter 1 2: Derm atitis
Chapter 1 3: Bacterial, Fungal, and Viral I nfections of the Skin
Chapter 1 4 : Psoriasis
Chapter 1 5: Acne Vulgaris and Rosacea
Chapter 1 6: O phthalmic Disorders
Chapter 1 7: O titis Media and O titis Externa
Chapter 1 8: Hy pertension
Chapter 1 9: Hy perlipidem ia
Chapter 20: Chronic Stable Angina and My ocardial I nfarction
Chapter 21 : Heart Failure
Chapter 22: Arrhy thmias
Chapter 23: Respiratory I nfections
Chapter 24 : Asthm a and Chronic O bstructive Pulmonary Disease
Chapter 25: G astric, Functional and I nflammatory Bowel Disorders
Chapter 26: G astroesophageal Reflux Disease and Peptic U lcer Disease
Chapter 27: Liv er Diseases
, Chapter 28: U rinary Tract I nfection
Chapter 29: Prostatic Disorders and Erectile Dy sfunction
Chapter 30: O v eractive Bladder
Chapter 31 : Sexually Transmitted I nfections
Chapter 32: O steoarthritis and G out
Chapter 33: O steoporosis
Chapter 34 : Rheumatoid Arthritis
Chapter 35: Headaches
Chapter 36: Seizure Disorders
Chapter 37: Alzheim er’s Disease
Chapter 38: Parkinson Disease
Chapter 39: Major Depressiv e Disorder and Bipolar Disorders
Chapter 4 0: Anxiety Disorders
Chapter 4 1 : Sleep Disorders
Chapter 4 2: Attention Deficit Hy peractivity Disorder
Chapter 4 3: Substance U se Disorders
Chapter 4 4 : Diabetes Mellitus
Chapter 4 5: Thy roid and Parathyroid Disorders
Chapter 4 6: Allergies and Allergic Reactions
Chapter 4 7: Hum an Immunodeficiency Virus
Chapter 4 8: O rgan Transplantation
Chapter 4 9: Pharm acotherapy for Select Throm boembolic Disorders
Chapter 50: Anem ias
Chapter 51 : I mmunizations
Chapter 52: Sm oking Cessation
Chapter 53: Weight Loss
Chapter 54 : Contraception
Chapter 55: Menopause
Chapter 56: Vaginitis
, Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
Answer: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
Answer: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
Answer: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
Answer: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
Answer: A PTS: 1
Approach, 5th Edition (Arcangelo & Peterson) | All Chapters 1–56| Questions &
100% Verified Answers And Rationales | A+ Graded
, T ABLE OF CONT ENT
Chapter 1 : I ssues for the Practitioner in Drug Therapy
Chapter 2: Pharm acokinetic Basis of Therapeutics and Pharm acody nam ic Principles
Chapter 3: I m pact of Drug I nteractions and Adv erse Ev ents on Therapeutics
Chapter 4 : Principles of Pharm acotherapy in Pediatrics, Pregnancy and Lactation
Chapter 5: Pharm acotherapy Principles in O lder Adults
Chapter 6: Principles of Antim icrobial Therapy
Chapter 7: Pharm acogenomics
Chapter 8: The Econom ics of Pharmacotherapeutics
Chapter 9: Principles of Pharm acology in Pain Managem ent
Chapter 1 0: Pain Management in O pioid U se Disorder (O U D) Patients
Chapter 1 1 : Cannabis and Pain Management
Chapter 1 2: Derm atitis
Chapter 1 3: Bacterial, Fungal, and Viral I nfections of the Skin
Chapter 1 4 : Psoriasis
Chapter 1 5: Acne Vulgaris and Rosacea
Chapter 1 6: O phthalmic Disorders
Chapter 1 7: O titis Media and O titis Externa
Chapter 1 8: Hy pertension
Chapter 1 9: Hy perlipidem ia
Chapter 20: Chronic Stable Angina and My ocardial I nfarction
Chapter 21 : Heart Failure
Chapter 22: Arrhy thmias
Chapter 23: Respiratory I nfections
Chapter 24 : Asthm a and Chronic O bstructive Pulmonary Disease
Chapter 25: G astric, Functional and I nflammatory Bowel Disorders
Chapter 26: G astroesophageal Reflux Disease and Peptic U lcer Disease
Chapter 27: Liv er Diseases
, Chapter 28: U rinary Tract I nfection
Chapter 29: Prostatic Disorders and Erectile Dy sfunction
Chapter 30: O v eractive Bladder
Chapter 31 : Sexually Transmitted I nfections
Chapter 32: O steoarthritis and G out
Chapter 33: O steoporosis
Chapter 34 : Rheumatoid Arthritis
Chapter 35: Headaches
Chapter 36: Seizure Disorders
Chapter 37: Alzheim er’s Disease
Chapter 38: Parkinson Disease
Chapter 39: Major Depressiv e Disorder and Bipolar Disorders
Chapter 4 0: Anxiety Disorders
Chapter 4 1 : Sleep Disorders
Chapter 4 2: Attention Deficit Hy peractivity Disorder
Chapter 4 3: Substance U se Disorders
Chapter 4 4 : Diabetes Mellitus
Chapter 4 5: Thy roid and Parathyroid Disorders
Chapter 4 6: Allergies and Allergic Reactions
Chapter 4 7: Hum an Immunodeficiency Virus
Chapter 4 8: O rgan Transplantation
Chapter 4 9: Pharm acotherapy for Select Throm boembolic Disorders
Chapter 50: Anem ias
Chapter 51 : I mmunizations
Chapter 52: Sm oking Cessation
Chapter 53: Weight Loss
Chapter 54 : Contraception
Chapter 55: Menopause
Chapter 56: Vaginitis
, Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
Answer: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
Answer: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
Answer: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
Answer: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
Answer: A PTS: 1
